Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-β therapy in the 3-year follow-up: a preliminary report

Frontiers Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability

Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges - ScienceDirect

Cross-validation of function for the separation of neuromyelitis optica

Frontiers Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome

IJMS, Free Full-Text

Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis

Frontiers Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome

Body fluid biomarkers in multiple sclerosis - The Lancet Neurology

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography - JL Bennett, J de Seze, M Lana-Peixoto, J Palace, A Waldman, S Schippling, S Tenembaum, B Banwell, B Greenberg, M